Redhill Biophrma ADR (RDHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2012 | 06-2012 | 03-2012 | |
| Sales | 3 | 5 | 4 |
| Gross Profit | 3 | 5 | 4 |
| Operating Income | 3 | 5 | 4 |
| Pre-tax Income | 3 | 5 | 4 |
| Net Income Continuous | -1,967 | -2,273 | -2,734 |
| Net Income | $-1,967 | $-2,273 | $-2,734 |
| EPS Basic Total Ops | -400.00 | -430.00 | -500.00 |
| EPS Basic Continuous Ops | -371.13 | -437.12 | -497.09 |
| EPS Diluted Total Ops | -400.00 | -430.00 | -500.00 |
| EPS Diluted Continuous Ops | -371.13 | -437.12 | -497.09 |
| EBITDA(a) | $3 | $5 | $4 |